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Editor: Yolanda PicóVolatilisation is one of themain pathways for pesticide emission to the atmosphere.While formulation strategies
and adjuvants are known to affect the fate of active ingredient, no general volatilisation reducing guidelines exist
for formulation purposes. Moreover, as limited information on formulation effects is available, current pesticide
fate models lack parameters characterising reduction of active ingredient volatilisation. The objective of this
study was to investigate the volatilisation reducing potential of formulation types and adjuvants, and to propose
an effective vapour pressure for pesticide fate modelling. Several formulations of fenpropimorph, pyrimethanil
and tebuconazole were produced and tested in a wind tunnel to evaluate the effect of formulation on active in-
gredient volatilisation. Produced emulsiﬁable concentrateswith high volatile solvents did not offer any reduction
in volatilisation, while the low volatile solvent reduced the volatilisation of pyrimethanil and fenpropimorph
with 79.2 and 52.9%, respectively. The microemulsion reduced the volatilisation of fenpropimorph, pyrimethanil
and tebuconazole with 57.6, 57.8 and 49.8%, respectively. High surfactant-active ingredient ratios (100:1) re-
duced the volatilisation of applied amount of pyrimethanil with 50%, on average. The effective vapour pressure
of pyrimethanil formulated as a commercial available suspension concentrate was reduced by 33.8%. The com-
mercial available emulsiﬁable concentrate did not reduce volatilisation of fenpropimorph. Effective vapour pres-
sures of formulated fenpropimorph and pyrimethanil were determined and showed a high correlation with the
amount volatilised within 48 h. The saturated vapour pressure is useful when comparing the volatility of active
ingredients, but effective vapour pressures are more appropriate to be used in pesticide fate models.
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729M. Houbraken et al. / Science of the Total Environment 633 (2018) 728–7371. IntroductionActive ingredient (a.i.) volatilisation from soil range from 1 to 30% of
the applied dosage (Bedos et al., 2002; Gish et al., 2011; Prueger et al.,
2017; Yates, 2006). Vapour losses from plant surfaces range from 1 to
50% for highly volatile active a.i.'s (Bedos et al., 2010; Leistra et al.,
2006; Leistra and Van Den Berg, 2007; Rudel, 1997; Willis and
McDowell, 1987).While an extensive amount of research has been con-
ducted on the quantiﬁcation of the volatilisation of either formulated or
technical a.i., only a few studies (Da Silva and Da Silva, 1998; Da Silva
et al., 2001; De Ruiter et al., 2003; Kubiak, 1999; Stevens and Bukovac,
1987) speciﬁcally focus on the inﬂuence of the formulation type and ad-
juvants. Volatilisation reducing strategies often consist of producing
controlled release formulations (Chen et al., 1994; Dailey, 2004;
Fernandez-Perez et al., 2014). Several coating materials exist for pro-
ducing capsules around the a.i. of interest (e.g. ethyl cellulose polyvinyl
alcohol, gelatin, sodium alginate, polyurea). More recently, the ability of
cyclodextrins to alter the physical, chemical, and biological properties of
guest molecules upon complexation, has been considered as an innova-
tive way to improve and/or develop new capsule formulations for crop
protection products (Morillo, 2006). Formulation as a salt increases the
water solubility of the a.i. and provides a lower vapour pressure by the
rigid crystallographic structure, which is useful for certain formulation
types.
To reduce the volatilisation rate and stability of volatile molecules,
ﬁxatives are often used in perfume formulations. A ﬁxative lowers the
vapour pressure, and thus, the volatility of the rawmaterial in a perfume
oil (Martinez-Guido et al., 2014). Although ﬁxatives are common in per-
fumery and personal care products [e.g. with DEET (Syed and Leal,
2008)], they are currently not included in agricultural formulations.
However, built-in adjuvants have been found to inﬂuence the
volatilisation of the formulated a.i.'s. Octylphenol surfactants reduce
the volatilisation of DDT on polytetraﬂuoroethylene dishes up to 70%
(Stevens and Bukovac, 1987).Moreover, when endosulfan is formulated
as an emulsiﬁable concentrate (EC), volatilisation from Phaseolus
vulgaris L. (common bean) leaves is distinctly higher than the
volatilisation of endosulfan formulated as a water dispersible powder
(Kubiak, 1999). Da Silva et al. (2001) observed that volatilisation of
technical triadimefon is slightly higher than the volatilisation of
triadimefon formulated as a wettable powder. Moreover, when chlor-
pyrifos is formulated on modiﬁed natural nanoclay, volatilisation is
clearly reduced (Xiang et al., 2014; Xiang et al., 2013). This is explained
by the opening of clogged pores in the clay, resulting in many micro-
nanopores, which foster chlorpyrifos adsorption.
Affected volatility is often characterised by an apparent or effective
vapour pressure of the a.i. in formulation compared to the saturated va-
pour pressure of the unformulated or technical a.i. (De Ruiter et al.,
2003; Lichiheb et al., 2016; Spencer and Cliath, 1970). However, only
the saturated vapour pressure of the technical a.i.'s is available in
literature.
Several models [PEARL, SURFATM-pesticide model, Pesticide emis-
sion model (PEM), PELMO] exist to estimate the volatilisation based
on meteorological data (temperature, humidity, precipitation and
solar radiation), physicochemical properties of the a.i. (vapour pressure
andmolecularweight) and agricultural practices (crop type, application
method, application rate) (Lichiheb et al., 2016; Scholtz et al., 2002; van
den Berg et al., 2016). All models use the saturated vapour pressure of
the a.i. to estimate the volatilisation. However, a.i.'s are formulated
with several adjuvants to ensure a stable and efﬁcient product. While
the effect of these adjuvants on plant penetration is incorporated in
models, their effect on the volatilisation is often neglected or omitted
as limited information is available. The SURFATM-Pesticide is one of
the rare models including a factor accounting for the effect of formula-
tion on the volatilisation (Lichiheb et al., 2016). However, limited data
are available to account for the formulation effect nor is there a vali-
dated quantiﬁcation technique.In-ﬂight a.i. volatilisation is limited to the smallest droplets and to
only a limited time window. Volatilisation from a.i. deposits on soil is
calculated to be 5 to 13 times lower than from a.i. deposits on plants
(Rudel, 1997) due to the increased turbulence above the foliage and
the poor adsorptive capacity of leaf surfaces (Boehncke et al., 1990;
Waymann and Rudel, 1995). Hence, the main focus in this study is the
reduction of the volatilisation of a.i., present as dried spray deposits,
through formulation. In this study, fenpropimorpf, pyrimethanil, and
tebuconazole are formulated with several adjuvants. Active ingredient
volatilisation is studied in wind tunnel experiments. Vapour pressure
measurments are performed using headspace solid-phase
microextraction. Active ingredients included in the study were selected
based on volatility, relevance for agriculture, stability on crop and in air.
The aims of this research is (i) to investigate the volatilisation reducing
potential of some formulation types, adjuvants and solvents which are
commonly used in commercial crop protection products, (ii) to propose
an effective vapour pressure to be used in environmental fatemodels to
improve the modelling of the volatilisation process.
2. Materials and methods
2.1. Reagents and materials
2.1.1. Active ingredients
Analytical standards of bifenthrin, diﬂufenican, fenpropimorph,
metalaxyl, pendimethalin, pyrimethanil, tebuconazole and tolylﬂuanid
were purchased from Sigma-Aldrich (Bornem, Belgium). Stock solu-
tions of analytical standards (1mga.i. L−1) of pendimethalin, bifenthrin,
metalaxyl, diﬂufenican, tolylﬂuanid, tebuconazole, fenpropimorph and
pyrimethanilwere prepared in hexane for use in the headspace analysis.
Stock solutions of fenpropimorph, pyrimethanil and tebuconazole were
also prepared in acetonitrile for use in the residue determination.Meth-
anol and acetonitrile were LC–MS grade, hexane was GC–MS grade and
were purchased from Merck (Darmstadt, Germany). Water was pro-
duced locally though a Milli-Q puriﬁcation system.
Commercial formulations of fenpropimorph (Corbel™, 750 g a.i. L−1,
emulsiﬁable concentrate, BASF), tebuconazole (Horizon™, 250 g a.i. L−1,
emulsiﬁable concentrate, Oxon Italia) and pyrimethanil (Scala™,
400 g a.i. L−1, suspension concentrate, BASF) were purchased. Technical
product of fenpropimorph and pyrimethanil was supplied by BASF
(Antwerp, Belgium). Technical product of tebuconazole was supplied
by Bayer (Diegem, Belgium). Physicochemical properties of a.i.'s in-
cluded in this research are shown in Supplementary Data, Table S1.
2.1.2. Adjuvants
An esteriﬁed canola oil (ethyl esteriﬁed seed oil, ESO) with emulsi-
ﬁers (Hasten™) was supplied by Surfaplus (Wageningen, The
Netherlands). Three alcohol ethoxylate surfactants with 3, 11 and 20
ethylene oxide (EO) additions (respectively Synperonic™ A3,
Synperonic™ A11 and Synperonic™ A20), a polymeric surfactant com-
bined with a nonionic surfactant blend (Atlox™ 4913 & 4894) and an
alkoxylated phosphate ester (Atplus™ 310) were provided by Croda
Crop Care (Goole, United Kingdom). A pinolene-based ﬁlm-forming
emulsion (Spraygard™), an antitranspirant, was supplied by Eastman
(Ghent, Belgium). An aromatic solvent (Solvesso™ 200ND) was sup-
plied by ExxonMobil (Antwerp, Belgium). All adjuvants are commonly
used in the formulation of crop protection products.
2.2. Preparation of formulations
Stock solutions of fenpropimorph, pyrimethanil and tebuconazole
were prepared in methanol (10,000 mg a.i. L−1) to keep concentration
equal over all trials. Stock solutions of adjuvants were prepared in
Milli-Q water (10,000 mg adjuvant L−1). Different amounts of a.i. and
adjuvant stock solution were combined to prepare the formulations.
All stock solutions were stored at 4 °C. Concentrations were used to
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and to be comparable over all laboratory trials.2.2.1. Effect of formulation on volatilisation of active ingredients
To evaluate the effect of the formulation type and the solvent volatil-
ity on the volatilisation of fenpropimorph, pyrimethanil and
tebuconazole, different formulations were produced.
The impact of formulation type on the volatilisation of
fenpropimorph, pyrimethanil and tebuconazole was studied by com-
paring an aqueous solution, a commercial formulation (an emulsiﬁable
concentrate for fenpropimorph and tebuconazole and a suspension con-
centrate for pyrimethanil) and a microemulsion. Aqueous solutions of
100 mg a.i. L−1 of fenpropimorph, pyrimethanil and tebuconazole
were prepared by diluting the stock solutions of the technical product
(in 100% methanol) with Milli-Q water (to produce aqueous solutions
with 10% v/v methanol).
The microemulsions were prepared bymixing 2.5 g of a.i. with 2.5 g
emulsiﬁer (Atplus™ 310) and adding dichloromethane until 10mLwas
reached while applying a low shear rate.
The impact of solvent volatility on the volatilisation of
fenpropimorph and pyrimethanil was evaluated by comparing two
emulsiﬁable concentrates, one with a low volatile aromatic solvent
(Solvesso™ 200ND, saturated vapour pressure ≤ 0.01 kPa) and another
with a high volatile solvent (dichloromethane, saturated vapour
pressure = 10 kPa), with their aqueous solution. The emulsiﬁable con-
centrations were produced by mixing 2.5 g a.i. with 2.5 g Synperonic™
A11 surfactant and adding the solvent (low volatile solvent (Solvesso™
200ND) and high volatile solvent (dichloromethane), respectively) to
10 ml while applying a low shear rate.
All formulations were diluted to 100 mg a.i. L−1 with Milli-Q water
for use in the wind tunnel. An overview of the produced formulation,
is given in Supplementary Data, Table S2.2.2.2. Effect of surfactant type on the volatilisation of pyrimethanil in sus-
pension concentrates
To evaluate the volatilisation reducing effect of different suspension
forming surfactants, four suspension concentrates of pyrimethanil were
produced using an IKA Ultra Turrax™ with a ﬁne homogenizer tip.
Pyrimethanil (20% w/w) was suspended with surfactant (20% w/w) in
Milli-Q water. An overview of the produced formulations, is given in
Supplementary Data, Table S3.2.2.3. Effect of tank-mix adjuvants on the volatilisation of active ingredients
To evaluate the effect of tank-mixed adjuvants on the volatilisation
of a.i.'s, different alcohol ethoxylates surfactants (Synperonic A3,
Synperonic A11 and Synperonic A20), a pinolene-based ﬁlm-forming
emulsion and a ESOwere tank-mixed with the commercial formulation
and the emulsiﬁable concentrate (high volatile solvent) of
fenpropimorph and pyrimethanil (100 mg a.i. L−1 and
100 mg adjuvant L−1 in ﬁnal spray solution). An overview of the pro-
duced formulations, is given in Supplementary Data, Table S4.2.2.4. Effect of concentration and degree of ethoxylation of alcohol
ethoxylates on the volatilisation of pyrimethanil
To evaluate the dosage effect of surfactants and the effect of the de-
gree of ethoxylation, aqueous solutions of pyrimethanil in methanol
(10% methanol) with different concentrations of alcohol ethoxylates
and an increasing degree of ethoxylation were produced. Stock solu-
tions of 100,000 mg L−1 of each adjuvant were made with Milli-Q
water. Spray solutions were made by combining the stock solution of
pyrimethanil in methanol with the adjuvant stock solutions, and were
diluted with Milli-Q water. An overview of the produced formulations,
is given in Supplementary Data, Table S5.2.3. Experimental set-up
2.3.1. Wind tunnel experiments
To quantify the volatilisation of fenpropimorph, pyrimethanil and
tebuconazole, dissipation experiments were performed according to
the protocol described by Houbraken et al. (2015). Active ingredient
samples are applied in a wind tunnel measuring 1.4 m long by 0.5 m
wide and 1.2mhigh. Thewind tunnel ismade out plasticwith a detach-
able top cover. Wind was generated with a Sodeca HEP-35-2M/H fan.
Thewind tunnel was equippedwith awind gauge, temperature and rel-
ative air humidity sensors. Samples were placed in, and taken out the
wind tunnel through the detachable hatch at the upper side. In total,
120 samples could simultaneously be placed in the wind tunnel. Air
temperature was kept constant at 21 °C (±2 °C). Wind speed was set
at 0.1 m s−1, and experiments were performed in the dark to minimise
photodegradation (Lavieille et al., 2008; Monadjemi et al., 2011). Rela-
tive humidity was measured during the experiments (20–45%) but
not controlled nor constant. From each solution, 1 mL was applied on
a non-porous glass surface (Petri dish, Ø = 0.035 m) and put into the
wind tunnel. Glass surfaces were chosen to minimise adsorption and
to exclude absorption. The applied volume, in combination with adju-
vants or solvents, was sufﬁcient to completely cover the bottom of the
dish, thus establishing a constant and comparable evaporation surface
for all tested formulations. Samples were periodically taken out until
8 days after application (after 0 h–6 h–24 h–48 h–72 h–120 h–168 h–
192 h). For each formulation tested (Section 2.2), three samples (n =
3) for each experimental point in time were analysed.
Active ingredientswere extracted from the glass surfaceswith 10mL
of acetonitrile and analysed using liquid chromatography-tandemmass
spectrometer detection (LC-MS/MS) (Section 2.4.1). To calculate the
dissipationwithout volatilisation (degradation), samples of the aqueous
solution of fenpropimorph, pyrimethanil and tebuconazole were sealed
before being placed in the wind tunnel (n = 3).
2.3.2. Indirect vapour pressure determination experiments using headspace
solid-phase microextraction
A correlation between the saturated vapour pressure and ﬁbre
uptake rate of bifenthrin, diﬂufenican, fenpropimorph, metalaxyl,
pendimethalin, pyrimethanil, tebuconazole and tolylﬂuanid was used
to determine the effective vapour pressure of formulated
fenpropimorph, pyrimethanil and tebuconazole. The relation between
the vapour pressure and the uptake rate into the solid-phase
microextraction (SPME) ﬁbre, coated with 100 μm polydimethylsilox-
ane (PDMS), was calculated according to Paschke et al. (2005). About
0.01 mg a.i. (of each formulation and analytical standard) was sealed
in a glass vial (2 mL). The vials were incubated in an oven at 25 °C (±
0.1 °C) for establishing a headspace atmosphere due to volatilisation
of the AI. The SPME ﬁbre was inserted through the vial septum and
moved out of the needle housing into the headspace. After
predetermined sampling times (0.5 to 30 min), the ﬁbre was retracted,
removed from the vial and immediately analysed on a gas chromatogra-
phy with a mass spectrometer detection (GC–MS) (Section 2.4.2). Four
separate samples were analysed for each experimental point in time
(n = 4).
2.4. Chemical analysis
2.4.1. LC-MS/MS instrumentation and operating conditions
Samples from thewind tunnel experiments were analysed on aWa-
ters ACQUITY UPLC™, equipped with a quaternary pump and mem-
brane degasser. The separation Acquity UPLC BEH C18, 130 Å, 1.7 μm,
2.1 mm × 50 mm column was kept at 40 °C. An automatic injector
was set to inject 10 μL per sample. The mobile phase components
were (A) a 0.1% formic acid in Milli-Q water and (B) acetonitrile with
0.1% formic acid. The gradient used was set at a ﬂow rate of
0.4 mL min−1 of 98% mobile phase A for 0.25 min. From 0.25 min to
731M. Houbraken et al. / Science of the Total Environment 633 (2018) 728–7377 min, a linear gradient was used to 98% mobile phase B, which was
maintained for 1 min. Then, a linear gradient was used to 98% mobile
phase A and maintained for 1 min. Sample analyses were performed
using a triple quadrupole system with electrospray ionisation (Waters
Xevo® TQD mass spectrometer detection; Waters, Zellik, Belgium).
The capillary needle was maintained at +2 kV. For operation in the
MS/MS mode, the following parameters were set: curtain gas (N2) at
7 bar; temperature 500 °C. The a.i.'s were monitored and quantiﬁed
using multiple reaction monitoring (MRM). Optimization of the MS/
MS conditions, identiﬁcation of the parent and product ions, as well as
the selection of the cone and collision voltages, was performed through
direct infusion of their individual standard solutions. After the optimiza-
tion of the collision cell energy, two different m/z transitions were se-
lected for each analyte, one for quantiﬁcation and one for
conﬁrmation. The MS/MS-transitions, ionisation mode, cone voltage
and collision energy are given in Supplementary Data, Table S6.
2.4.2. GC–MS instrumentation and operating conditions
Headspace samples were analysed with an Agilent 6890N gas chro-
matograph, equippedwith an Agilent 5973mass spectrometer detector
(GC–MS), an on-column, split/split less capillary injection system and a
HP-5MS (5% phenyl methyl siloxane) capillary column (30 m ×
0.25 mm × 0.25 μm ﬁlm thickness). The operating conditions were as
follows: the column was initially set at a temperature of 100 °C for
1 min, then, the temperature was increased at a rate of 25 °C min−1 to
300 °C and held for 4 min at 300 °C. Helium was used as carrier gas at
a ﬂow rate of 1.9 mL min−1. MS detection was performed in selected
ion monitoring (SIM) acquisition mode. The retention times and m/z
values of all a.i.'s used in the experiments are given in Supplementary
Data, Table S7.
2.4.3. Scanning electron microscope
The physical appearance of the dry deposits in the wind tunnel ex-
periments were illustrated by scanning electron microscopy (SEM). So-
lutions of 1000mga.i. L−1,with corresponding adjuvant concentrations,
were prepared for pyrimethanil in the aqeuous solution, commercial
suspension concentrate, and emulsiﬁable concentratewith the aromatic
solvent. After application and drying on stubs, the samples were coated
with gold following the procedure detailed by Steel et al. (2011) and ob-
served with a JSM-840 EM (JEOL) at 12 kV (Steel et al., 2011).
2.5. Analytical performance
To test selectivity of the analytical equipment, the individual analyt-
ical standards were injected, followed by a mixture of the analytical
standards to check whether interference was present. Blank samples
were analysed (n = 3) following the same analytical method to check
for the absence of interference peaks of degradation products, impuri-
ties and the matrix. A reagent blank was also made and all the steps of
the extraction process were followed to check whether there were in-
terference peaks from solvents, consumables used and the a.i.'s. The lin-
earity of each a.i. was tested using the linear regressions of the
calibration curve and the coefﬁcient of determination (R2) was calcu-
lated. The repeatability was evaluated by the coefﬁcient of variation
(CoV) of the measurement from each standard concentration and for
each active ingredient. The accuracy was evaluated by using the
spiked-placebo recovery method (Corley, 2002). After 24 h in the
wind tunnel, blank samples were spiked at two levels [high (1 mg a.
i. L−1) and low (0.02 mg a.i. L−1) concentration], analysed under the
same conditions (same day, same operator) and compared with blank
samples without spiked active ingredient. The ratio of the calculated
amount to the expected amount expressed as a percentage was used
to assess the recovery. The obtained recoveries, the limit of detection
(LOD) and the limit of quantiﬁcation (LOQ) for a.i.'s analysed on the
GC–MS and LC-MS/MS are given in Supplementary Data, Tables S8
and S9, respectively. The results show that the average recovery wasbetween 92.1 and 108.3%. The results demonstrate that a.i.'s were accu-
rately determined with a LOQ below 20 μg L−1.
2.6. Data processing
2.6.1. Volatilisation of active ingredients in a wind tunnel
The emission rate of volatile organic compounds for a source is as-
sumed to decrease exponentially in time (Bukowski and Meyer, 1995;
Sparks, 1991). Including ﬁrst order degradation, Da Silva and Da Silva
(1998) proposed that the amount of a.i. could be describe by Eq. (1):
dM
dt
¼−k1 exp−k2tM−k3M ð1Þ
where M is the amount of the a.i. (mg m−2) left, and k1 (day−1), k2
(day−1) and k3 (day−1) being the dissipation rate constants. With deg-
radation being negligible (k3), the dissipation of a.i.'s from the solid/gas
interface, described by Da Silva et al. (2001), assumes an exponential
decaying volatilisation rate:
ln
M
M0
 
¼ k1
k2
exp−k2t−1
 
ð2Þ
In the model, M0 is the total amount of applied a.i. (mg m−2), k1 re-
fers to the volatilisation rate of the a.i. and k2 to the exponential decay of
the volatilisation rate, which is included to account for the volatilisation
reducing effect of matrix-forming formulations. Residue data were
ﬁtted to Eq. (2), by least-squares optimization (R-software). From the
model, amounts volatilised within 48 h were calculated. Zero order or
ﬁrst order models could also be used, but do not cover all possible for-
mulation effects (Chen et al., 1994). When data from a ﬁrst order
volatilisation experiment was modelled with the model assuming an
exponential decay of the emission rate, the model reduced to a ﬁrst-
order equation.
2.6.2. Headspace solid-phase microextraction
A linear regression of quantiﬁedﬁbre uptake rates of the 8 a.i.'s (Sup-
plementary Data, Table S1) versus their saturated vapour pressureswas
constructed (Supplementary Data, Fig. S1). The inverse of this relation
was used to calculate the effective vapour pressure of target formula-
tions from the determined ﬁbre uptake rates (Paschke et al., 2005) ac-
cording to Eq. (3):
y ¼ x=564:28 ð3Þ
where x is the ﬁbre uptake (ng min−1) and y is the effective vapour
pressure (mPa) of the a.i.'s. The effect of the formulation on
volatilisation was calculated according to Eq. (4) (Lichiheb et al., 2016):
fcor ¼ Peffective=Psaturated ð4Þ
With fcor the correction factor accounting for the effect of formula-
tion on volatilisation (−), Psaturated the saturated vapour pressure of
the formulated a.i. (Pa) and Peffective themeasured effective vapour pres-
sure (Pa).
3. Results
Dissipation experiments with sealed samples showed that dissipa-
tion of fenpropimorph, pyrimethanil and tebuconazole within 48 h
was only 4.5, 3.0 and 0.9% of the initial deposit amount, respectively,
corresponding to k3 values of 0.023, 0.015 and 0.004 day−1 (Supple-
mentary Data, Table S10). Moreover, 8 days after application, only
16.9, 11.3 and 3.5% was dissipated. As dissipation due to degradation
is minimised, dissipation in non-sealed samples in the wind tunnel
can reasonably be attributed to volatilisation. Hence, Eq. (2) was used
tomodel the observed residue data were by least-squares optimization.
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Volatilisation of the a.i. in the aqueous solutionwas the highest of all
formulations for pyrimethanil and tebuconazole. For fenpropimorph, no
statistical difference (Welch t-test: p-value N 0.05) between the com-
mercial emulsiﬁable concentrate and the aqueous solution was found.
Fenpropimorph showed the highest volatilisation rate, followed by
pyrimethanil and tebuconazole, as shown in Figs. 1 and 3. Volatilisation
results were in agreement with the saturated vapour pressure of the a.
i.'s. An overview of dissipation rate constants, effective vapour pressure
and amount volatilisedwithin 48 h of fenpropimorph, pyrimethanil and
tebuconazole in aqueous solutions, commercial products,
microemulsions and emulsiﬁable concentrationswith high and low vol-
atile solvents is given in Supplementary Data, Table S11.
3.1.1. Fenpropimorph
About 66.2% of the fenpropimorph applied as an aqueous solution
was volatilised in 2 days (Fig. 1). Of the commercial formulation,
73.5% was volatilised, but there was no statistical difference with the
aqueous solution, nor with the emulsiﬁable concentrate with the high
volatile solvent (p-value N 0.05). Effective vapour pressure was
7.2 mPa, 6.9 mPa and 7.0 mPa for the aqueous solution, the commercial
emulsiﬁable concentrate and the emulsiﬁable concentratewith the high
volatile solvent, respectively (no statistical difference, p-value N 0.05),
which is in good agreement with the saturated vapour pressure. Com-
pared to the aqueous solution, the microemulsion reduced the amount
of fenpropimorf that volatilised in 48 h from 66.2 to 28.1%, generating a
volatilisation reducing potential of 57.6%. Effective vapour pressure of
fenpropimorph in themicroemulsion decreased to 1.9mPa. The emulsi-
ﬁable concentrate with the low volatile solvent reduced the
volatilisation from 66.2 to 13.8%, a reduction of 79.2%. When consider-
ing the relative importance of degradation (Supplementary Data,
Table S10) after 48 h of volatilisation, degradation accounted for 6.8,
6.2, 16.1, 6.1 and 32.7% of the observed volatilisation for respectively
the aqueous solution, the commercial formulation, the microemulsion
and the emulsiﬁable concentrates with a high and low volatile solvent.
Correction factors for the saturated vapour pressure, compared to
the aqueous solution, were calculated to be 0.95 for the commercial
emulsiﬁable concentrate, 0.26 for themicroemulsion, 0.97 for the emul-
siﬁable concentratewith the high volatile solvent and 0.10 for the emul-
siﬁable concentrate with the low volatile solvent.
3.1.2. Pyrimethanil
After 2 days, the volatilised amount of pyrimethanil applied as an
aqueous solution was calculated to be 59.2% (Fig. 1). After 7 days, N90%0
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Fig. 1.Volatilised amount of fenpropimorph (left) and pyrimethanil (right) formulated as anaqu
with a high and low volatile solvent. All spray solutions had a concentration of 100mg a.i. L−1. T
suspension concentrate for pyrimethanil.was volatilised. Effective vapour pressure of the applied pyrimethanil
(2.2 mPa) was in good agreement with the saturated vapour pressure of
2.1 mPa.When comparing the different formulations, the microemulsion
had the lowest volatilisation rate (k1), which is also reﬂected by a low ef-
fective vapour pressure of 1.1 mPa. Volatilisation of pyrimethanil in the
microemulsion was reduced from 59.2 to 25.0% after 48 h, yielding a
volatilisation reducing potential of 57.8%. The suspension concentrate
was able to reduce the effective vapour pressure to 1.4 mPa (reduction
of 34%). Volatilisation of pyrimethanil in an aqueous solutionwas reduced
from 59.2 to 43.7% by the suspension concentrate and to 27.9% by the
emulsiﬁable concentrate with a low volatile solvent, providing a
volatilisation reducing potential of 26.2 and 52.9%, respectively. Relative
importance of degradation (Supplementary Data, Table S10) after 48 h
of volatilisation was 5.0, 6.8, 11.8, 5.4 and 10.6% of the observed
volatilisation for respectively the aqueous solution, the commercial for-
mulation, the microemulsion and the emulsiﬁable concentrates with a
high and low volatile solvent. Correction factors for the saturated vapour
pressure were calculated to be 0.63 for the commercial suspension con-
centrate, 0.50 for themicroemulsion, 0.99 for the emulsiﬁable concentrate
with the high volatile solvent and 0.58 for the emulsiﬁable concentrate
with the low volatile solvent.
Scanning electron micrographs of three evaluated pyrimethanil for-
mulations (1000 mg a.i. L−1) were taken, 24 h after application to illus-
trate the difference in deposits of formulation types (Fig. 2). The crystals
of the aqueous solution are triclinic andhave a size of about 10 μm.Biolog-
ical activity of the aqueous solution will be poor as no homogeneous dis-
tribution is achieved for the preventive activity of pyrimethanil. Nor will
the curative activity be present as crystalline a.i.'s are not readily taken
up by the plants. The crystals in the commercial formulation have a
smaller particle size (±0.1 μm) and no distinct form, both a result of the
formulation process (milling). The spray solution is scattered homoge-
neously which is achieved by the adjuvants in the product. In the emulsi-
ﬁable concentration, no crystals were observed as the low volatile
aromatic solvent prevents their formation. The observed black spots,
(i.e. viscous solvent with dissolved pyrimethanil) are scattered homoge-
neously by the adjuvants. Furthermore, penetration into the plant (cura-
tive action) is promoted as the a.i. remains solubilised.
3.1.3. Tebuconazole
Volatilisation rates of tebuconazole are signiﬁcantly lower than for
fenpropimorph and pyrimethanil, which is in accordancewith their sat-
urated and effective vapour pressures. After 48 h, 22.3% of the applied
tebuconazole in the aqueous solution is volatilised (Fig. 3). Although
the volatilisation of the aqueous solution is low, the microemulsion of
tebuconazole was able to further reduce the volatilisation rate. When0
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eous solution, a commercial formulation, amicroemulsion and an emulsiﬁable concentrate
he commercial formulationwas an emulsiﬁable concentrate (EC) for fenpropimorph; and a
733M. Houbraken et al. / Science of the Total Environment 633 (2018) 728–737formulated as a microemulsion, volatilisation of tebuconazole reduced
from 22.3 to 11.2%, yielding a volatilisation reducing potential of
49.8%. Relative importance of degradation (Supplementary Data,
Table S10) after 48 h of volatilisation was 3.9, 4.5 and 7.8% of the ob-
served volatilisation for respectively the aqueous solution, the commer-
cial formulation and the microemulsion.
The volatilisation reducing potential of the commercial formulation
(emulsiﬁable concentrate) is poor and not statistical different from the
aqueous solution (p-value N 0.05), which is in accordance with the re-
sults for the commercial emulsiﬁable concentrate of fenpropimorph.
Correction factors for the saturated vapour pressure (fcor) were calcu-
lated to be 0.97 for the commercial emulsiﬁable concentrate and 0.16
for the microemulsion.
3.2. Volatilisation reducing effect of adjuvants
3.2.1. Volatilisation reducing effect of tank-mix adjuvants
The alcohol ethoxylate surfactants had the smallest volatilisation re-
ducing effect and appeared to have no effect (p-value N 0.05) on theFig. 2. Deposits of three pyrimethanil formulations (1000 mg a.i. L−1) on a glass surface:
(a) aqeuous solution, (b) commercial suspension concentrate, (c) emulsiﬁable
concentrate with the aromatic solvent.volatilisation of fenpropimorph, neither in the commercial formulation
nor in the emulsiﬁable concentrate with the high volatile solvent (di-
chloromethane), and the commercial suspension concentrate of
pyrimethanil, as shown in Supplementary Data, Table S12. However,
they seem to reduce the volatilisation of pyrimethanil in the emulsiﬁ-
able concentrate from 55 to 45, 40 and 32.6% for the alcohol ethoxylates
with respectively 3, 11 and 20 additions of ethylene oxide. Correction
factors were calculated compared to the saturated vapour pressure of
the formulation with no adjuvants. Except for the emulsiﬁable concen-
trate of pyrimethanil, all alcohol ethoxylates seem to have correction
factors between 1.08 and 0.88.
The esteriﬁed seed oil reduced the volatilisation of fenpropimorph
with 32 and 41% for respectively the emulsiﬁable concentrate with the
high volatile solvent and the commercial EC, as illustrated in Fig. 4. The
ESO provide correction factor for the saturated vapour pressure of 0.36
and 0.53 for fenpropimorph, respectively (Supplementary Data,
Table S12). The volatilisation of pyrimethanil in the emulsiﬁable concen-
trate formulation was reduced with 12% and had a correction factor of
0.77. No effect of the esteriﬁed seed oil on the volatilisation of
pyrimethanil in the commercial suspension concentrate was observed
(p-value N 0.05). The pinolene-based ﬁlm-forming emulsion reduced
the volatilisation of fenpropimorph in the commercial emulsiﬁable con-
centrate with 25%, the fenpropimorph and pyrimethanil in the emulsiﬁ-
able concentrate with the high volatile solvent with 36 and 18%,
respectively. For the pyrimethanil in the commercial suspension concen-
trate, again, no effect was observed (Fig. 4), and the correction factor for
the vapour pressure was calculated to be 1.1. An overview of the dissipa-
tion rate constants, effective vapour pressure, correction factors and
amount volatilisedwithin 48 h is given in Supplementary Data, Table S12.
3.2.2. Volatilisation reducing effect of surfactant type in suspension
concentrates
While the volatilisation of pyrimethanil in suspensions was signiﬁ-
cantly lower than the volatilisation from aqueous solution (Fig. 5),
there were no signiﬁcant differences between the different suspension
concentrates with different surfactants (Supplementary Data,
Table S13). The suspension concentrate with the alcohol ethoxylates
with 20 ethylene oxide units had the lowest volatilisation rate (k1 =
0.24) of pyrimethanil, but was not statistically lower than its commer-
cial formulation (p-value N 0.05). Therewere no signiﬁcant effects on ef-
fective vapour pressure, irrespective of the type of surfactant used.0
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Fig. 3. Volatilised amount of tebuconazole formulated as an aqueous solution, a
commercial formulation and a microemulsion. All spray solutions had a concentration of
100 mg a.i. L−1. The commercial formulation was an emulsiﬁable concentrate (EC).
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Fig. 4.Volatilised amount of commercial emulsiﬁable concentrate of fenpropimorphand a commercial suspension concentrate of pyrimethanil tank-mixedwith an alcohol ethoxylatewith
3, 11 and 20 ethylene oxide (EO) additions, with an esteriﬁed seed oil, with a pinolene-based ﬁlm-forming emulsion and without a tank-mix adjuvant. All spray solutions had a
concentration of 100 mg a.i. L−1 and 100 mg adjuvant L−1.
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pressure of pyrimethanil to the aqueous solution and were between
0.66 and 0.77.
3.2.3. Effect of concentration and degree of ethoxylation of alcohol
ethoxylates on the volatilisation of pyrimethanil
At low surfactant concentrations, (1–100 mg L−1), there was no dif-
ference (p-value N 0.05) in the volatilisation of pyrimethanil between
the aqueous solution and the formulationswith the alcohol ethoxylates,
irrespective of thedegree of ethoxylation. The amount volatilisedwithin
48 h ranged from 57 to 69% (Supplementary Data, Table S14).While the
reduction in pyrimethanil volatilisation by the alcohol ethoxylate with
20 ethylene oxide units appears to increase at a concentration of
100 mg L−1 (ratio 1:1), no statistical difference was found between
the three alcohol ethoxylates. Correction factors were calculated using
the saturated vapour pressure of pyrimethanil in the aqueous solution
and were between 1.01 and 0.87, with 0.92 as average. At higher con-
centration (1000 and 10,000 mg L−1, surfactant-a.i. ratio of 10:1 and
100:1 respectively), volatilisation of pyrimethanil seems reduced for
each alcohol ethoxylate. However, no statistical difference (p-value N
0.05) in pyrimethanil volatilisation reducing capacity is observed be-
tween alcohol ethoxylates with 3, 11 and 20 ethylene oxide units. Aver-
age volatilised amount of pyrimethanil reduced from 63% at 1 mg0
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Fig. 5. Left: volatilised amount of pyrimethanil in suspension concentrates (SC)using 5 different
i. L−1) differing in concentration of alcohol ethoxylate (1–10,000 mg L−1) with 20 ethylene oxadjuvantL−1 to 13% at 10000 mg adjuvant L−1, providing a reduction
of 79.4%. Effective vapour pressure of pyrimethanil decreased from
2.2 mPa at surfactant concentration of 1 mg L−1 to b0.08mPa at surfac-
tant concentration of 10,000 mg L−1. The average correction factor is
lowered to 0.10. The volatilisation of pyrimethanil inﬂuenced by the al-
cohol ethoxylate with 20 ethylene oxide units at different concentra-
tions is illustrated in Fig. 5. An overview of the volatilisation reducing
potential of all concentrations for the three surfactants is given in Sup-
plementary Data, Table S14.3.3. Correlation between effective vapour pressure and amount volatilised
Although the experimental set-up used in this study
represents a worst-case scenario, the measured effective vapour
pressure correlated very well with the amount volatilised after
48 h for both pyrimethanil (r = 0.911, p-value b 0.01) and
fenpropimorph (r = 0.933, p-value b 0.01). Fig. 6 demonstrates
that a.i.'s with a high effective vapour pressure, exhibited higher
volatilisation after a 48 h exposure in a wind tunnel. For
pyrimethanil, a drop of 1 mPa in the effective vapour pressure,
corresponded with a decline in volatilisation with 19.3 percentage
points (pp). For fenpropimorph, a 1 mPa reduction in effective
vapour pressure, reduced volatilisation with 9.0 pp.0
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Fig. 6.Correlation and 95% conﬁdence interval between the volatilised amount in 48 h and
effective vapour pressure of pyrimethanil and fenpropimorph in different formulations
with or without tank-mix adjuvants.
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4.1. Reduction in volatilisation of active ingredients
Dissipation due to degradation, 48 h after application, accounted for
16.1, 11.8 and 7.8% of the volatilisation of fenpropimorph, pyrimethanil
and tebuconazole applied as a microemulsion, respectively. However,
during extraction, some volatilisation might have occurred, as dissipa-
tion without volatilisation was highest for the active ingredient with
the highest saturated vapour pressure, and decreased with decreasing
saturated vapour pressure (Supplementary Data, Table S10). Dissipa-
tion without volatilisation appeared to be low, which is in accordance
with the observations of Da Silva et al. (2001).
Among formulation types tested, the aqueous solution showed the
highest volatilisation rates as no adjuvants or low volatile solvents are
present. Upon drying of the spray solution, active ingredients with
high melting points (pyrimethanil and tebuconazole) are left
crystallised, and available to volatilise unprotected, as illustrated for
pyrimethanil in the SEM monograph (Fig. 2a). The commercial emulsi-
ﬁable concentrate of fenpropimorphand the emulsiﬁable concentrate of
fenpropimorph andpyrimethanil with a high volatile solvent did not re-
duce the volatilisation neither, in contrast to the emulsiﬁable concen-
trate of fenpropimorph and pyrimethanil (Fig. 2c) with the low
volatile solvent. High volatile solvents evaporate before any effect on
the volatilisation of the active ingredient can be achieved. The lower
the vapour pressure of the solvent, the longer the active ingredient is
protected from volatilisation. The fast evaporation of dichloromethane
rapidly exposes the fenpropimorph and pyrimethanil to volatilisation,
while the aromatic solvent (Solvesso™) traps the active ingredients in
a protective matrix. By diffusion, the active ingredient might arrive at
the interface with the gas phase, leading to a diffusion determined
volatilisation, and evaporate according to their partitioning constants.
This was in line with Chen et al. (1994) who found lower volatility of
chlorpyrifos when emulsiﬁed in a low volatile matrix (abietic acid es-
ters) (Chen et al., 1994). The volatilisation reducing potential of low vol-
atile solvents also explains the low concentrations of fenpropidin and
epoxiconazole found in the air despite a great difference in saturated va-
pour pressure (saturated vapour pressurefenpropidin=17mPa; saturated
vapour pressureepoxiconazole= 0.01mPa) (Ellis et al., 2010). In both com-
mercial formulations, low volatile aromatic solvents [Solvesso™ 150 in
Opus and Solvesso™ 200 in Alpha Fenpropidin (BASF, 2003;
Makhteshim Agan, 2006)] are present, which can greatly reduce thevolatility of active ingredients. The low volatile solvent lowers the
volatilisation rate of the active ingredients, bringing the difference in
concentrations in the air between fenpropidin and epoxiconazole to
the level of the variability on themeasurements, explaining the absence
of a volatilisation difference (Ellis et al., 2010). Several solvents for use in
agricultural formulations cover a wide range of vapour pressures (e.g.
aromatic solvents: 0.01 kPa, cyclohexanone: 10 kPa) and might affect
the volatilisation of active ingredients.
In contrast to their effect on both pyrimethanil and fenpropimorph
in emulsiﬁable concentrates, the tank-mix adjuvants do not seem to
have any volatilisation reducing effect on pyrimethanil in a suspension
concentrate. This might be explained by the water dispersible proper-
ties of suspensions and their stability towards coagulation. The solid
particles in suspension concentrates are completely shielded, producing
a volatilisation reducing effect (Supplementary Data, Table S13), but
tank-mix adjuvants are unable to interact. Further research should in-
vestigate whether this is due to the type of formulation, or due to the
formulation process.
Microemulsions are thermodynamic stable as a result of the interac-
tion with both active ingredient and solvent. The active ingredient is
shielded and volatilisation is reduced. Likewise, the esteriﬁed seed oil
and the pinolene-based ﬁlm-forming emulsion entrap the active ingre-
dient, protecting them from volatilisation.When a high adjuvant-active
ingredient concentration ratio is present, the adjuvant seems to act as a
viscous matrix as well. This is seen with the alcohol ethoxylates that
were able to reduce total pyrimethanil volatilisation from 63 to 13%
when the adjuvant-active ingredient ratio was increased from 1:1 to
100:1. As an adjuvant-active ingredient concentration ratio of 1:1, or
lower, is often observed in commercial formulations, the built-in surfac-
tants presumablywill not signiﬁcantly inﬂuence the volatilisation of the
active ingredients. For commercial products in which the concentration
of adjuvants is markedly higher than the active ingredient concentra-
tion, a reduction in the volatilisation of active ingredient might be pos-
sible. In contrast, the degree of ethoxylation seems ofminor importance
for the volatilisation mitigation ability of alcohol ethoxylates.
Volatilisation was studied on an inert, hydrophilic surface (glass),
providing homogeneous deposits from where volatilisation occurred.
In the ﬁeld, volatilisation occurs form plant or soil surfaces, which
could affect the produced deposit. As leaf surfaces contain epicuticular
wax, penetration into the plant increases and acts as a competing pro-
cess, reducing the amount of active ingredients available to volatilise.
More hydrophobic surfaces (leaf surfaces) might give other, heteroge-
neous deposits for active ingredient volatilisation, which should be in-
vestigated further. However, a clear volatilisation rate with minimal
variability is obtainedwhenworkingwithminimised photodegradation
and surface interaction. Next step is the implementation of the effective
vapour pressure in a pesticide fatemodel where variability is accounted
for by incorporating penetration into the plant and degradation
processes.
Before implementing a volatilisation mitigation strategy in practice,
its impact on residue levels and pest control efﬁcacies of the formulated
active ingredient needs to be evaluated. A reduced volatilisation of a fo-
liar applied active ingredient could increase the residue on the crops. As
less active ingredient is volatilised, the applied dosagemight be reduced
without substantial loss in efﬁcacy, reducing the residues on the crop.
4.2. Use of effective vapour pressure as a volatilisation reduction parameter
Effective vapour pressures of fenpropimorph and pyrimethanil were
equal to their saturated vapour pressure for the aqueous solution and
emulsiﬁable concentrate with a high volatile solvent. As the water and
solvent (methanol and dichloromethane) were already volatilised
upon drying, the active ingredients were left to volatilise unprotected.
When combined with certain adjuvants and concentrations, it seems
that the partitioning between the active ingredient deposit and the va-
pour phase favoured the deposit. As the saturated vapour pressure
736 M. Houbraken et al. / Science of the Total Environment 633 (2018) 728–737measurements are taken from unformulated active ingredients, it ap-
pears that adjuvants strongly interactwith the active ingredients and af-
fect the measurements of the effective vapour pressure. The increasing
correction factors for the saturated vapour pressure due to increasing
adjuvant concentrations might be explained by the dilution with the
low volatile alcohol ethoxylates, acting as a liquid solution (Raoult's
law). Further research is necessary to clarify this.
A correlation coefﬁcient of 0.911 for pyrimethanil and 0.933 for
fenpropimorph indicates a strong relationship between the effective va-
pour pressure and the amount volatilised within 48 h. Due to the ab-
sence of penetration into the plant and photodegradation, high
correlation values were obtained. Guth et al. (2004) also observed this
relation between the vapour pressure and observed volatilisation, but
the correlationwasweaker (Guth et al., 2004).When includingpenetra-
tion into the plant, photodegradation and formulation effects, correla-
tion might become stronger.
For fenpropimorph, saturated vapour pressure of both 7.0 mPa
(EFSA, 2008b) and 4.2 mPa (Krohl et al., 1998) at 25 °C are available in
literature, increasing the uncertainty in vapour pressure values. Both
the uncertainty in saturated vapour pressure values and the absence
of formulation effect, makes volatilisation difﬁcult to model. The use of
an effective vapour pressure incorporates the effect of adjuvants and
formulation type on the volatilisation of active ingredients. Headspace
analysis offers an easy-to-use method to evaluate the effective vapour
pressure of an active ingredient in formulation and can be used to spe-
ciﬁcally measure the effective vapour pressure of crop protection prod-
ucts applied in the ﬁeld. Furthermore, the effective vapour pressure
seems to be useful to compare the volatility of active ingredients be-
tween different experiments.
5. Conclusion
Formulation types and adjuvantsmay have a signiﬁcant effect on the
volatilisation of active ingredient from glass surfaces. Depending on the
adjuvants and formulation type used, formulation of active ingredient
can provide a reduction in volatilisation up to 79% compared to active
ingredient volatilisation from aqueous solutions. Using low volatile sol-
vents appears to be an easy and robust method to reduce the
volatilisation. Individual volatilisation reducing potentials of adjuvants
are active ingredient speciﬁc and should be measured ad hoc.
The saturated vapour pressure is useful when comparing the volatil-
ity with other active ingredients, but is not appropriate when working
with formulated products or with pesticide fate models. Effective va-
pour pressure of pyrimethanil formulated in a commercial available
suspension concentrate was 34% lower than its saturated vapour
pressure.
When calculating the emission of active ingredients into the envi-
ronment, effective vapour pressure should be used. It allows accurate
estimation of the volatilisation potential of formulated active ingredi-
ents and is easily and accurately measurable.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.scitotenv.2018.03.186.
Additional details on the physicochemical properties of the active in-
gredients are given in Table S1. A detailed overview on the produced
formulations is given in Tables S2 to S4.More information on the chem-
ical analysis and the recovery of the active ingredients is given in
Tables S5 to S9. An overview of dissipation results of formulation
types of fenpropimorph, pyrimethanil and tebuconazole without
volatilisation is given in Table S10. An overview of dissipation results
of formulation types of fenpropimorph, pyrimethanil and tebuconazole
is given in Table S11. An overview of the dissipation results of
fenpropimorph and pyrimethanil for the tank-mix products is given in
Table S12. Dissipation results for pyrimethanil in suspension concen-
trates with different surfactants are given in Table S13. An overview of
the effect of surfactant concentration on the dissipation results ofpyrimethanil, is given in Table S14. Fig. S1 illustrates the relation of
the ﬁbre uptake rates the to saturated vapour pressure.Acknowledgements
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